Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19138595

HER2 and response to paclitaxel in node-positive breast cancer

Author
HAYES, Daniel F1 ; THOR, Ann D2 ; HENDERSON, I. Craig9 ; NORTON, Larry10 ; WINER, Eric P11 ; HUDIS, Clifford A10 ; ELLIS, Matthew J12 ; BERRY, Donald A13 ; DRESSIER, Lynn G3 ; WEAVER, Donald4 ; EDGERTON, Susan2 ; COWAN, David3 ; BROADWATER, Gloria5 ; GOLDSTEIN, Lori J6 ; MARTINO, Silvana7 ; INGLE, James N8
[1] University of Michigan Comprehensive Cancer Center, Ann Arbor, United States
[2] University of Colorado Comprehensive Cancer Cente r, Aurora, United States
[3] Lineberger Comprehensive Can cer Center at the University of North Carolina, Chapel Hill, United States
[4] University of Vermont Cancer Center, Fletcher Allen Health Care, Burlington, United States
[5] Cancer and Leukemia Group B Statistical Center, Duke University, Durham, NC, United States
[6] Fox Chase Comprehensive Cancer Center, Philadelphia, United States
[7] the Angeles Clinic and Research Institute, Santa Monica , CA, United States
[8] Mayo Clinic, Rochester, MN, United States
[9] University of California at San Francisco, San Francisco, United States
[10] Memorial Sloan-Kettering Cancer Center, New York, United States
[11] Dana-Farber Cancer Institute, Boston, United States
[12] Siteman Cancer Center, Washington University School of Medicine, St. Louis, United States
[13] M.D. Anderson Cancer Center, Houston, United States
Cancer and Leukemia Group B (CALGB) Investigators, United States
Source

The New England journal of medicine. 2007, Vol 357, Num 15, pp 1496-1506, 11 p ; ref : 42 ref

CODEN
NEJMAG
ISSN
0028-4793
Scientific domain
General medicine general surgery
Publisher
Massachusetts Medical Society, Boston, MA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Glande mammaire Gène erbB2 Gène onc cellulaire Médecine Noeud Paclitaxel Protooncogène Tumeur maligne Cancer du sein Récepteur HER2 Antimitotique Glande mammaire pathologie Taxane dérivé
Keyword (en)
Antineoplastic agent Mammary gland erbB2 Gene C-Onc gene Medicine Node Paclitaxel Protooncogene Malignant tumor Breast cancer Human Epidermal growth factor Receptor 2 Antimitotic Mammary gland diseases Taxane derivatives
Keyword (es)
Anticanceroso Glándula mamaria Gen erbB2 Gen onc celular Medicina Nudo Paclitaxel Protooncogen Tumor maligno Cáncer pecho Antimitótico Glándula mamaria patología Taxane derivado
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors

Discipline
Generalities in medical sciences Gynecology. Andrology. Obstetrics
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
19138595

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web